14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PHVS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in Pharvaris B.V. stock price on Thursday moving 21.83% between high and low
(Updated on Apr 25, 2024)

Buy candidate since Apr 25, 2024 PDF

The Pharvaris B.V. stock price gained 7.15% on the last trading day (Thursday, 25th Apr 2024), rising from $21.25 to $22.77. During the last trading day the stock fluctuated 21.83% from a day low at $19.70 to a day high of $24.00. The price has risen in 6 of the last 10 days and is up by 2.06% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 49 thousand more shares were traded than the day before. In total, 82 thousand shares were bought and sold for approximately $1.87 million.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $23.06 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -30.19% during the next 3 months and, with a 90% probability hold a price between $12.30 and $16.10 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PHVS Signals & Forecast

Mostly positive signals in the chart today. The Pharvaris B.V. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $20.71 and $22.76. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 23.62%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Pharvaris B.V. stock

Pharvaris B.V. finds support from accumulated volume at $22.27 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $4.30 between high and low, or 21.83%. For the last week, the stock has had daily average volatility of 14.60%.

Our recommended stop-loss: $21.86 (-3.98%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 5 days ago.)

Trading Expectations (PHVS) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Pharvaris B.V. to open at $22.16, and during the day (based on 14 day Average True Range), to move between $20.63 and $24.91, which gives a possible trading interval of +/-$2.14 (+/-9.39%) up or down from last closing price. If Pharvaris B.V. takes out the full calculated possible swing range there will be an estimated 18.77% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $23.23 (2.02%) than the support at $22.27 (2.20%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Pharvaris B.V. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 2.666 Buy Candidate Upgraded

Predicted Opening Price for Pharvaris B.V. of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$22.16 ( 2.69%) $22.77

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PHVS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 26.46 16.19 %
R2 24.81 8.98 %
R1 23.80 4.52 %
Current price: 22.77
Support S1 20.51 -9.91 %
S2 19.50 -14.36 %
S3 17.86 -21.58 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 26.69 17.22 %
R2 24.16 6.10 %
R1 23.23 2.02 %
Current price 22.77
Support S1 22.27 -2.20%
S2 21.20 -6.90%
S3 20.15 -11.51%

FAQ

What is the symbol for Pharvaris B.V. Stock and on which exchange is it traded?
The symbol for Pharvaris B.V. is PHVS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Pharvaris B.V. Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy Pharvaris B.V. Stock?
Pharvaris B.V. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pharvaris B.V. Stock.

What's the current price of Pharvaris B.V. Stock?
As of the end of day on the Apr 25, 2024, the price of an Pharvaris B.V. (PHVS) share was $22.77.

What is the 52-week high and low for Pharvaris B.V. Stock?
The 52-week high for Pharvaris B.V. Stock is $33.00 and the 52-week low is $7.93.

What is the market capitalization of Pharvaris B.V. Stock?
As of the Apr 25, 2024, the market capitalization of Pharvaris B.V. is 1.225B.

When is the next earnings date for Pharvaris B.V.?
The upcoming earnings date for Pharvaris B.V. is Aug 05, 2024.
Click to get the best stock tips daily for free!

About Pharvaris B.V.

Pharvaris B.V. Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks and is under Phase 2 clinical ... PHVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT